Blog Posts in October, 2011
Posted on Oct 31, 2011 By The Senators Firm
Regulatory officials at the U.S. Food and Drug Administration (FDA) continue to caution consumers of the transgressions being committed by the dietary supplement industry. Subsequently, several ...
Continue reading "Reumofan Plus Tablets Recalled Due to the Presence of Undisclosed Ingredients" »
Posted on Oct 29, 2011 By The Senators Firm
Warning: Gadolinium-based contrast agents may cause a number of severe side effects as well as an extremely serious condition called Nephrogenic Systemic Fibrosis (NSF). If you or a loved one has been ...
Continue reading "Gadolinium Lawyer & Lawsuit" »
Posted on Oct 28, 2011 By The Senators Firm
The United States Food & Drug Administration is responsible for the safety and effectiveness of health related products. FDA approves drugs and medical devices based on pre-marketing tests ...
Continue reading "FDA Encourages Consumers to Report Adverse Reactions Associated with Drugs, Medical Devices and Dietary Supplements" »
Posted on Oct 26, 2011 By The Senators Firm
In October 2010, The U.S. Food & Drug Administration (FDA) required Merck & Co. Inc., the manufacturer of Fosamax (generic: Alendronate sodium) to change the labeling on the osteoporosis drug ...
Continue reading "Fosamax® Femur Fracture Lawyer & Lawsuit" »
Posted on Oct 24, 2011 By The Senators Firm
Update – 4/26/2011 – Recent studies published in the British Medical Journal acknowledge an increased risk of venous thromboembolism, a severe form of blood clotting deep within the body, ...
Continue reading "Ocella® Lawyer & Lawsuit" »
Posted on Oct 21, 2011 By The Senators Firm
After recently hearing of the sexual abuse allegations leveled at a former elementary school teacher, victims are continuing to come forward. Mark Berndt, who has already been arrested on 23 separate ...
Continue reading "Sexual Abuse Victims of Former Elementary School Teacher Continue to Come Forward" »
Posted on Oct 20, 2011 By The Senators Firm
X-Hero and Male Enhancer “dietary supplements” were recalled after the U.S. Food and Drug Administration (FDA) revealed that the products actually contained undisclosed prescription ...
Continue reading "X-Hero and Male Enhancer Lawyer & Lawsuit" »
Posted on Oct 14, 2011 By The Senators Firm
As recent as July 2011, the U.S. Food and Drug Administration (FDA) issued an updated safety communication regarding the safety and effectiveness of transvaginal mesh products. The safety ...
Continue reading "AdvaMed Reveals New Information In Light Of Transvaginal Mesh Meeting" »
Posted on Oct 12, 2011 By The Senators Firm
On February 8, 2011, ABC News Investigates (Chris Cuomo) published this very informative article/video regarding the link between the popular denture cream Fixodent and Neuropathy. You can learn more ...
Continue reading "Fixodent Linked to Neuropathy - ABC News Investigates" »
Posted on Oct 11, 2011 By The Senators Firm
Reclast (zoledronic acid) is intended to be used in the treatment and prevention of osteoporosis, glucocorticoid-induced osteoporosis and Paget’s disease. Each of which have the ability to ...
Continue reading "Reclast® Kidney Failure Lawyer & Lawsuit" »
Posted on Oct 11, 2011 By The Senators Firm
At approximately four inches long and two inches wide, Mini Vehicle sets produced by Green Toys provide children with a fun means of entertainment. Of significant concern, however, are recent reports ...
Continue reading "Green Toys Mini Vehicle Recall Lawsuit" »
Posted on Oct 8, 2011 By The Senators Firm
The U.S. Food and Drug Administration (FDA) has been busy distributing warning letters to those in violation of the Current Good Manufacturing Practice (CGMP) rules. The recent recipients of these ...
Continue reading "FDA Warns Facilities in Violation of CGMP Rules" »
Posted on Oct 6, 2011 By The Senators Firm
In an attempt to avoid, what could be, overwhelming ramifications for medical device manufacturers, industry leaders in transvaginal mesh production have acknowledged the need for increased safety ...
Continue reading "FDA and Vaginal Mesh Manufacturers Square Off at Meeting; FDA Says Mesh Not Proven Safe or Effective for Vaginal Prolapse" »
Posted on Oct 6, 2011 By The Senators Firm
Kaletra (generic: lopinavir/ritonavir) is an oral solution that is used in the treatment of the infection caused by the human immunodeficiency virus (HIV). Kaletra is designed to inhibit the ...
Continue reading "Kaletra® Lawyer & Lawsuit" »
Posted on Oct 6, 2011 By The Senators Firm
Chron’s disease is an inflammatory bowel disease (IBD) characterized by inflammation and ulcers that affect the lining of the digestive tract. The disease can often be debilitating and may also ...
Continue reading "Chron's Disease® Lawyer & Lawsuit" »
Posted on Oct 5, 2011 By The Senators Firm
A ventricular septal defect (VSD) is a congenital birth defect that affects the hearts septum, the wall that separates the left and right sides of the heart. This defect is characterized by a hole in ...
Continue reading "Ventral Septal Defects Lawyer & Lawsuit" »
Posted on Oct 5, 2011 By The Senators Firm
Yasmin Lawsuit Update: Officials at the U.S. Food and Drug Administration (FDA) held a meeting on December 8 to discuss the safety and effectiveness of Bayer’s popular Yasmin. According to ...
Continue reading "Yasmin® Lawyer & Lawsuit" »
Posted on Oct 4, 2011 By The Senators Firm
Today, the FDA is meeting with its obstetric and gynecologic medical devices “advisory committee” to “help” the Agency decide the fate of surgical mesh devices commonly used in ...
Continue reading "Commentary: Why The Pelvic Surgical Mesh Debacle Is The Latest Example Of FDA's Inability To Protect Consumers" »
Posted on Oct 4, 2011 By The Senators Firm
The popular osteoporosis medication Fosamax (alendronate sodium) has been linked to osteonecrosis of the Jaw (ONJ), femur fractures, and severe musculoskeletal pain. If you or a loved one has been ...
Continue reading "Fosamax® Lawyer & Lawsuit" »
Posted on Oct 1, 2011 By The Senators Firm
A panel of U.S. Food and Drug Administration (FDA) advisors has convened in Gaithersburg, MD to discuss the future of transvaginal mesh products. The meeting was called after an influx of adverse ...
Continue reading "FDA's Medical Device Classification Process In Question" »